FEDERAL COURT OF AUSTRALIA
Kenquist Nominees Pty Limited v Campbell (No 3) [2017] FCA 1230
File number: NSD 1364 of 2015 Judge: YATES J Date of judgment: 20 October 2017 Catchwords: PRACTICE AND PROCEDURE – discovery of documents – agreed protocol for discovery – claims of privilege from production – form and content of lists of documents required to be given Legislation: Federal Court Rules 2011 (Cth) r 20.17
Federal Court of Australia Act 1976 (Cth)
Cases cited: Budden v Wilkinson [1893] 2 Q.B. 432
Braegrove Pty Ltd v Bendeich [1993] 2 Qd.R. 239
Domino’s Pizza Enterprises Ltd v Precision Tracking Pty Ltd (No 3) [2017] FCA 1063
Fig Tree Developments Ltd v Australian Property Custodian Holdings Ltd [2008] FCA 1041
Guy Carpenter and Co Pty Ltd v Grove (No 3) [2011] FCA 1250
Interchase Corporation Ltd (in liquidation) v Grosvenor Hill QLD Pty Ltd (No 2) (1999) 1 QdR 163
Kenquist Nominees Pty Ltd v Campbell (No 2) [2016] FCA 911
Lazenby v Zammit [1987] Tas.R. 54
Taylor v Batten (1878) 4 Q.B.D. 85
Date of hearing: 5 October 2017 Registry: New South Wales Division: General Division National Practice Area: Commercial and Corporations Sub-area: Corporations and Corporate Insolvency Category: Catchwords Number of paragraphs: 68 Counsel for the Applicant: Mr Martin SC with Mr Bagley Solicitor for the Applicant: Corrs Chambers Westgarth Counsel for the First, Second and Third Respondents: Mr R A Yezerski Solicitor for the First, Second and Third Respondents: Norton Rose Fulbright Australia Counsel for the Fourth Respondent: Mr P Jammy Solicitor for the Fourth Respondent: Wotton + Kearney Counsel for the Fifth Respondent: Mr L T Livingston Solicitor for the Fifth Respondent: Sparke Helmore Lawyers Counsel for QRxPharma Limited: Mr T Maltz Solicitor for QRxPharma Limited: Arnold Bloch Leibler ORDERS
NSD 1364 of 2015 BETWEEN: KENQUIST NOMINEES PTY LIMITED ACN 008 797 224 ATF THE KENQUIST SUPERANNUATION FUND
Applicant
AND: PETER CAMPBELL and others
Respondents
JUDGE:
YATES J
DATE OF ORDER:
20 OCTOBER 2017
THE COURT ORDERS THAT:
1.The applicant’s amended interlocutory application dated 18 September 2017 be dismissed to the extent that it seeks the relief claimed in paragraphs 1 to 5 thereof.
2.The applicant pay the first to third respondents’, fourth respondent’s, fifth respondent’s, and QRxPharma Limited’s costs of and incidental to the applicant’s claims for relief referred to in Order 1.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
REASONS FOR JUDGMENT
YATES J:
INTRODUCTION
By an amended interlocutory application filed on 18 September 2017, the applicant seeks orders pursuant to r 20.17(2)(c) and r 20.17(3)(b) of the Federal Court Rules 2011 (Cth) (FCR) to the effect that the first to fifth respondents (the respondents) file updated or more detailed lists of documents describing with greater particularity the documents in respect of which claims of privilege from production are made, and the grounds of the claimed privilege. The applicant contends that if this further particularity is not provided, it should…
Keep reading for free
Create a free CaseChat account to read Kenquist Nominees Pty Limited v Campbell (No 3) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2017] FCA 1230
- Decision Date
CaseChat Overview and Summary
The primary legal issue before the court was whether the applicant had properly followed the agreed protocol for discovery, as expected by the Court’s Central Practice Note, and whether the respondents were required to provide a list of documents under the Federal Court Rules without an order, as stated in Rule 20.12. The court also had to determine the appropriate form and content of the lists of documents to be given, considering the claims of privilege made by the respondents.
In addressing these issues, the court highlighted the importance of cooperation between parties and their lawyers in minimising the burden of discovery and adhering to the overarching purpose of the Court's civil practice and procedure. The court noted that parties should discuss discovery issues and, if possible, agree on a protocol that could obviate the need for strict compliance with the Federal Court Rules. The court emphasised that discovery should facilitate the just resolution of the proceeding as quickly, inexpensively and efficiently as possible. The court concluded that the applicant had not adequately followed the agreed protocol for discovery and that the claims of privilege needed further substantiation.
The court dismissed the applicant’s claims for relief in paragraphs 1 to 5 of the amended interlocutory application and ordered the applicant to pay the costs of the respondents and QRxPharma Limited for the claims referred to in the order. The dismissal was based on the failure to follow the agreed protocol and the inadequacy of the claims of privilege. The court's decision underscored the necessity for parties to approach discovery with the goal of efficient and cost-effective resolution of disputes.
Orders
Orders of the court
1. The applicant’s amended interlocutory application dated 18 September 2017 be dismissed to the extent that it seeks the relief claimed in paragraphs 1 to 5 thereof.
2. The applicant pay the first to third respondents’, fourth respondent’s, fifth respondent’s, and QRxPharma Limited’s costs of and incidental to the applicant’s claims for relief referred to in Order 1.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.